COMPLEX REGIONAL PAIN SYNDROME MARKET ANALYSIS

Complex Regional Pain Syndrome MarketSize and Trends

Global Complex Regional Pain Syndrome Market: Dynamics

The rising number of patients suffering from complex regional pain syndrome (CRPS), chronic pain, and failed back syndrome are the key factors driving the growth of the complex regional pain syndrome market. For instance, in 2017, there were 219,317 prevalent cases of CRPS in the U.S.

Moreover, the rising number of initiatives undertaken by non-profit organizations, increasing R&D funding by private and public organizations, and various government initiatives to increase the awareness about the syndrome are expected to drive the market growth during the forecast period. For instance, U.S. Pain Foundation, a non-profit organization, is dedicated to serving those who live with conditions that cause chronic pain. The mission of the U.S. Pain Foundation is to empower, educate, and connect people struggling with painful chronic conditions.

Furthermore, increasing R&D activities and FDA approvals of upcoming drugs are expected to drive the market growth during the forecast period. For instance, in September 2021, FDA granted orphan drug status to Soin Therapeutics, an Ohio based pharmaceutical company, for low dose Naltrexone (LDN) to treat Complex Regional Pain Syndrome (CRPS).